.svg){kind=small}
Jan-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Quality Drugs has shown a consistent presence in the Edible category within Oregon, maintaining a stable rank between 9th and 10th place from October 2024 to January 2025. This consistency in ranking suggests a solid foothold in the market, although there was a noticeable decline in sales from December 2024 to January 2025. Despite this dip, their ability to stay within the top 10 indicates resilience and a steady consumer base. The brand's performance in other states and categories, however, remains undisclosed, which could suggest either a lack of presence or a strategic focus on specific markets.
In terms of category performance, Quality Drugs' position in the Edible market of Oregon is commendable, yet it does not appear in the top 30 for other categories or states. This absence could be interpreted as a potential area for growth or a strategic decision to concentrate efforts where they are most effective. The stability in their ranking within the Edible category highlights a strong product offering that resonates with consumers in Oregon, but it also raises questions about their visibility and impact in other regions and categories. Further insights into their strategies and performance across different markets could provide a more comprehensive understanding of their overall market dynamics.
Competitive Landscape
In the competitive landscape of the Oregon edible cannabis market, Quality Drugs has experienced a relatively stable yet challenging position over the past few months. From October 2024 to January 2025, Quality Drugs maintained a rank of 9th or 10th, indicating a consistent presence in the top tier but also highlighting a need for strategic improvements to climb higher. Notably, Hapy Kitchen consistently outperformed Quality Drugs, securing ranks between 7th and 9th, with sales figures that were significantly higher, particularly in November and December 2024. Meanwhile, Private Stash showed a positive trajectory, improving from 10th to 8th place by January 2025, suggesting effective strategies that Quality Drugs might consider emulating. Despite a dip in sales in January 2025, Quality Drugs remained ahead of Mr. Moxey's and Botz, which consistently ranked lower. This competitive analysis underscores the importance for Quality Drugs to innovate and adapt to maintain and improve its market position in Oregon's edible category.
Notable Products
In January 2025, the top-performing product for Quality Drugs was the Cherry Lime & Blue Raspberry Cosmic Pop Gummy (100mg), maintaining its first-place rank from December 2024 with sales reaching 3413 units. The Mellow Mango Gummy (100mg) rose to the second position, improving from fourth place in December 2024, indicating a growing popularity. The CBD/CBN/THC 1:1:1 Berry Bonanza Gumdrops 10-Pack (100mg CBD, 100mg CBN, 100mg THC) held steady at third place, although its sales slightly decreased from the previous month. The Super Sour Apple Gummy (100mg) dropped to fourth place from its second-place position in December 2024. Finally, the Wavy Watermelon Gummy (100mg) remained consistent at fifth place, showing stable sales performance over the past months.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
